221 related articles for article (PubMed ID: 3891432)
1. [The dynamic property of glucagon secretion in response to blood glucose--analysis with the aid of the control theory using an artificial endocrine pancreas].
Yagi T
Nihon Naibunpi Gakkai Zasshi; 1985 Feb; 61(2):69-79. PubMed ID: 3891432
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of glucagon infusion algorithms for a counterregulatory system in artificial endocrine pancreas.
Yagi T; Yamasaki Y; Bando K; Kawamori R; Kamada T; Shichiri M
Med Prog Technol; 1988; 13(4):195-201. PubMed ID: 2972904
[TBL] [Abstract][Full Text] [Related]
3. Counterregulatory system in an artificial endocrine pancreas. Glucose infusion algorithm.
Yamasaki Y; Shichiri M; Kawamori R; Goriya Y; Sasai T; Morishima T; Nomura M; Tohdo R; Abe H
Artif Organs; 1979 Aug; 3(3):265-70. PubMed ID: 394725
[TBL] [Abstract][Full Text] [Related]
4. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
Vranic M; Kawamori R; Pek S; Kovacevic N; Wrenshall GA
J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
[TBL] [Abstract][Full Text] [Related]
5. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
[TBL] [Abstract][Full Text] [Related]
6. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon.
Giacca A; Fisher SJ; McCall RH; Shi ZQ; Vranic M
Endocrinology; 1997 Mar; 138(3):999-1007. PubMed ID: 9048601
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
[TBL] [Abstract][Full Text] [Related]
8. Effect of caerulein upon insulin and glucagon secretion in dogs.
Ohneda A; Horigome K; Ishii S; Kai Y; Chiba M
Horm Metab Res; 1978 Jan; 10(1):7-11. PubMed ID: 344181
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
[TBL] [Abstract][Full Text] [Related]
10. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.
Igawa K; Mugavero M; Shiota M; Neal DW; Cherrington AD
Diabetes; 2002 Oct; 51(10):3033-42. PubMed ID: 12351444
[TBL] [Abstract][Full Text] [Related]
11. BASREP: a method for maintaining euglycemia during somatostatin suppression of pancreatic secretion.
Pacini G; Ader M; Bergman RN
Comput Methods Programs Biomed; 1992 Mar; 37(2):107-15. PubMed ID: 1353714
[TBL] [Abstract][Full Text] [Related]
12. Taurine supplementation ameliorates glucose homeostasis, prevents insulin and glucagon hypersecretion, and controls β, α, and δ-cell masses in genetic obese mice.
Santos-Silva JC; Ribeiro RA; Vettorazzi JF; Irles E; Rickli S; Borck PC; Porciuncula PM; Quesada I; Nadal A; Boschero AC; Carneiro EM
Amino Acids; 2015 Aug; 47(8):1533-48. PubMed ID: 25940922
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
[TBL] [Abstract][Full Text] [Related]
14. Role of glucagon in countering hypoglycemia induced by insulin infusion in dogs.
Dobbins RL; Connolly CC; Neal DW; Palladino LJ; Parlow AF; Cherrington AD
Am J Physiol; 1991 Dec; 261(6 Pt 1):E773-81. PubMed ID: 1767838
[TBL] [Abstract][Full Text] [Related]
15. Role for autonomic nervous system to increase pancreatic glucagon secretion during marked insulin-induced hypoglycemia in dogs.
Havel PJ; Veith RC; Dunning BE; Taborsky GJ
Diabetes; 1991 Sep; 40(9):1107-14. PubMed ID: 1682196
[TBL] [Abstract][Full Text] [Related]
16. A feasibility study of bihormonal closed-loop blood glucose control using dual subcutaneous infusion of insulin and glucagon in ambulatory diabetic swine.
El-Khatib FH; Jiang J; Damiano ER
J Diabetes Sci Technol; 2009 Jul; 3(4):789-803. PubMed ID: 20144330
[TBL] [Abstract][Full Text] [Related]
17. Central factors in the control of insulin and glucagon secretion.
Porte D; Woods SC; Chen M; Smith PH; Ensinck JW
Pharmacol Biochem Behav; 1975; 3(1 Suppl):127-33. PubMed ID: 775499
[TBL] [Abstract][Full Text] [Related]
18. The structure-function relationship of GLP-1 related peptides in the endocrine function of the canine pancreas.
Ohneda A; Ohneda K; Ohneda M; Koizumi F; Ohashi S; Kawai K; Suzuki S
Tohoku J Exp Med; 1991 Nov; 165(3):209-21. PubMed ID: 1807008
[TBL] [Abstract][Full Text] [Related]
19. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.
Banarer S; McGregor VP; Cryer PE
Diabetes; 2002 Apr; 51(4):958-65. PubMed ID: 11916913
[TBL] [Abstract][Full Text] [Related]
20. The development of an artificial beta cell system and its validation in depancreatized dogs: the physiological restoration of blood glucose homeostasis.
Goriya Y; Kawamori R; Shichiri M; Abe H
Med Prog Technol; 1979 Jun; 6(3):99-108. PubMed ID: 481366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
